Page last updated: 2024-11-13

xiamycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

xiamycin: from Streptomyces sp.; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID38358410
CHEMBL ID1270030
MeSH IDM0555905

Synonyms (5)

Synonym
hydroxy(dimethyl)[?]carboxylic acid
xiamycin
CHEMBL1270030
(3s,4s,4ar,13bs)-3-hydroxy-4,13b-dimethyl-2,3,4,4a,5,6,8,13b-octahydro-1h-naphtho[2,1-b]carbazole-4-carboxylic acid
xiamycin a
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (31)

Assay IDTitleYearJournalArticle
AID527051Antimicrobial activity against Candida albicans at 50 ug after 24 hrs by paper disk method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527058Antimicrobial activity against Enterococcus faecalis 1528 R10 at 50 ug after 24 hrs by paper disk method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527054Antimicrobial activity against Mycobacterium vaccae IMET 10670 at 50 ug after 24 hrs by paper disk method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527066Antitumor activity against human PAXF 1657L by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID1289314Selectivity index, ratio of CC50 for African green monkey Vero cells to EC50 for PEDV infected in African green monkey Vero cells2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Antiviral Indolosesquiterpenoid Xiamycins C-E from a Halophilic Actinomycete.
AID1289316Cytotoxicity against African green monkey Vero cells after 48 hrs by MTT assay2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Antiviral Indolosesquiterpenoid Xiamycins C-E from a Halophilic Actinomycete.
AID527052Antimicrobial activity against Penicillium notatum JP36 at 50 ug after 24 hrs by paper disk method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527053Antimicrobial activity against Bacillus subtilis ATCC 6633 at 50 ug after 24 hrs by paper disk method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527048Antimicrobial activity against Pseudomonas aeruginosa SG137/B7 at 50 ug after 24 hrs by paper disk method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID1289315Antiviral activity against PEDV infected in African green monkey Vero cells assessed as reduction in virus-induced cytopathic effect after 72 hrs by MTT assay2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Antiviral Indolosesquiterpenoid Xiamycins C-E from a Halophilic Actinomycete.
AID527072Antiproliferative activity against human K562 cells2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527060Antitumor activity against human GXF251L by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527073Antiproliferative activity against human HeLa cells2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527067Antitumor activity against human 22Rv1 by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527069Antitumor activity against human RXF 486L by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527056Antimicrobial activity against Staphylococcus aureus SG 511 at 50 ug after 24 hrs by paper disk method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527068Antitumor activity against human PXF 1752L by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527063Antitumor activity against human MAXF 401NL by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527050Antimicrobial activity against Sporobolomyces salmonicolor SBUG 549 at 50 ug after 24 hrs by paper disk method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527064Antitumor activity against human MEXF 462NL by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527065Antitumor activity against human OVXF 899L by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527059Antitumor activity against human HT-29 by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527047Inhibition of HIV1 NL4-3 replication in CD4-CCR5 expressing human TZM-bl cells assessed as decrease in p24 antigen production2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527071Antiproliferative activity against mouse L929 cells2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527062Antitumor activity against human LXFL 529L by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527070Antitumor activity against human UXF 1138L by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527055Antimicrobial activity against Pseudomonas aeruginosa K799/61 at 50 ug after 24 hrs by paper disk method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527049Antimicrobial activity against Escherichia coli SG458 at 50 ug after 24 hrs by paper disk method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID526858Inhibition of HIV1 NL4-3 replication in CD4-CXCR4 expressing human TZM-bl cells assessed as decrease in p24 antigen production2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527061Antitumor activity against human LXFA 629L by modified propidium iodide assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
AID527057Antimicrobial activity against Staphylococcus aureus 134/94 R9 at 50 ug after 24 hrs by paper disk method2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]